NeuroOne Medical Technologies
NMTC
21 hedge funds and large institutions have $2.4M invested in NeuroOne Medical Technologies in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
17% more funds holding
Funds holding: 18 → 21 (+3)
10% more capital invested
Capital invested by funds: $2.19M → $2.4M (+$211K)
0.33% less ownership
Funds ownership: 1.64% → 1.31% (-0.33%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$46.3K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$22K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.8K |
| 4 |
MW
Marcum Wealth
Cleveland,
Ohio
|
+$10K |
| 5 |
FFA
Farther Finance Advisors
San Francisco,
California
|
+$2.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Mayo Clinic
Rochester,
Minnesota
|
-$145K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$127K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$47.7K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$13.9K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$8K |
NMTC Hedge Fund Activity: Q3 2024 in Review
21 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q3 2024, worth a combined $2.4M — up 9.7% from $2.19M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NMTC positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was William Blair & Company, opening a new position worth an estimated $46.3K. The largest seller was Mayo Clinic, exiting entirely with an estimated $145K sold.
- 21 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q3 2024, up from 18 in Q2 2024.
- Funds reported $2.4M of NeuroOne Medical Technologies stock for Q3 2024, up 9.7% quarter-over-quarter.
- 6 funds opened new NeuroOne Medical Technologies positions in Q3 2024 and 3 closed out, a net change of +3 holders.
- The largest NeuroOne Medical Technologies buyer in Q3 2024 was William Blair & Company, an estimated $46.3K added.
- The largest NeuroOne Medical Technologies seller in Q3 2024 was Mayo Clinic, an estimated $145K sold.
Based on aggregated 13F filings for Q3 2024.